150 related articles for article (PubMed ID: 1551059)
1. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma.
Osinaga E; Pancino G; Beuzelin M; Babino A; Rodriguez D; Robello C; Tiscornia A; Phillips E; Bourguignat A; Roseto A
Cancer; 1992 Apr; 69(7):1745-9. PubMed ID: 1551059
[TBL] [Abstract][Full Text] [Related]
2. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL; Fogt F; Goonewardene S
Cancer; 2000 Aug; 90(4):230-4. PubMed ID: 10966563
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections.
Charpin C; Pancino G; Osinaga E; Bonnier P; Lavaut MN; Allasia C; Roseto A
Anticancer Res; 1992; 12(1):209-23. PubMed ID: 1567169
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
9. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
11. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal.
Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H
Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025
[TBL] [Abstract][Full Text] [Related]
12. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions.
Magyarosy E; Martin WJ; Chu EW; Martin SE
Pathol Oncol Res; 1999; 5(1):32-5. PubMed ID: 10079375
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies.
Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI
Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893
[TBL] [Abstract][Full Text] [Related]
15. Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions.
Barberis MC; Faleri M; Veronese S; Casadio C; Viale G
Acta Cytol; 1997; 41(6):1757-61. PubMed ID: 9390137
[TBL] [Abstract][Full Text] [Related]
16. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature.
Davidson B
Anal Cell Pathol; 2001; 23(3-4):107-28. PubMed ID: 12082292
[TBL] [Abstract][Full Text] [Related]
18. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report.
Wasserman L; Neri A; Kaplan B; Manor Y; Galli M; Hardy B
J Cancer Res Clin Oncol; 1995; 121(7):387-92. PubMed ID: 7543483
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of p53 and ki67 immunostaining for distinguishing benign from malignant serous effusions.
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2011 Dec; 23(4):155-62. PubMed ID: 22776843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
